GalenOps prod · 0.1.0

Sites & risk-based monitoring

Risk scores combine serious adverse events, open QA findings, and flagged visits. High-risk sites trigger a proposed on-site visit that a CRA must confirm.

List 53

SiteCountryPrincipal investigatorStatusRisk score
SITE001 (USA) USA Dr. Reyes activated KRI 0.174
SITE002 (USA) USA Dr. Nolan activated KRI 0.283
SITE003 (CAN) CAN Dr. Okafor activated KRI 0.239
SITE004 (DEU) DEU Dr. Tanaka activated KRI 0.139
SITE005 (FRA) FRA Dr. Muller activated KRI 0.328
SITE006 (GBR) GBR Dr. Rossi activated KRI 0.444
SITE007 (JPN) JPN Dr. Dubois activated KRI 0.252
SITE008 (KOR) KOR Dr. Kim activated KRI 0.299
SITE009 (AUS) AUS Dr. Novak activated KRI 0.387
SITE010 (ESP) ESP Dr. Silva activated KRI 0.381
SITE011 (ITA) ITA Dr. Jansen activated KRI 0.306
SITE012 (BRA) BRA Dr. Kowalski activated KRI 0.384
SITE013 (USA) USA Dr. Clarke activated KRI 0.467
SITE014 (NLD) NLD Dr. Moreau activated KRI 0.438
SITE015 (POL) POL Dr. Ito activated KRI 0.308
The University of Texas MD Anderson Cancer Center (Houston, TX) USA Dr. Reyes activated unscored
Sylvester Comprehensive Cancer Center, University of Miami (Miami, FL) USA Dr. Nolan activated unscored
Duke Cancer Institute (Durham, NC) USA Dr. Okafor in_activation unscored
Robert H. Lurie Comprehensive Cancer Center of Northwestern University (Chicago, IL) USA Dr. Tanaka in_activation unscored
Sarcoma Oncology Center (Santa Monica, CA) USA Dr. Reyes activated KRI 0.21
Stanford University (Stanford, CA) USA Dr. Nolan activated KRI 0.237
University of Iowa (Iowa City, IA) USA Dr. Okafor activated KRI 0.218
Pennsylvania Hematology Oncology Associates (Philadelphia, PA) USA Dr. Tanaka activated KRI 0.0
CTRC Institute for Drug Development, University of Texas (San Antonio, TX) USA Dr. Muller activated KRI 0.312
Royal North Shore (St Leonards, Australia) AUS Dr. Rossi activated KRI 0.0
Epworth HealthCare Clinical Trials and Research Centre (Richmond, Australia) AUS Dr. Dubois activated KRI 0.391
Border Medical Oncology (Wodonga, Australia) AUS Dr. Kim activated KRI 0.0
Royal Hobart Hospital (Hobart, Australia) AUS Dr. Novak activated KRI 0.409
Royal Perth Hospital (Perth, Australia) AUS Dr. Silva activated KRI 0.496
Mount Medical Centre (Perth, Australia) AUS Dr. Jansen activated KRI 0.0
The Crown Princess Mary Cancer Centre Westmead (Sydney, Australia) AUS Dr. Kowalski activated KRI 0.276
State Health Centre Oncology Department (Budapest, Hungary) HUN Dr. Clarke activated KRI 0.359
Hemato Oncology Clinic, Vedanta Institute of Medical Science (Thaltej, India) IND Dr. Moreau activated KRI 0.0
Hemato Oncology Clinic, Vedanta Institute of Medical Science (Ahmedabad, India) IND Dr. Ito activated KRI 0.32
M.S. Ramaiah Medical College and Hospitals (Bangalore, India) IND Dr. Reyes activated KRI 0.0
Curie Manavata Cancer Centre (Nashik, India) IND Dr. Nolan activated KRI 0.0
Delhi State Cancer Institute (Pune, India) IND Dr. Okafor activated KRI 0.0
Jehangir Clinical Development Centre Pvt Ltd (Pune, India) IND Dr. Tanaka activated KRI 0.0
Delhi State Cancer Institute (Mandoli, India) IND Dr. Muller activated KRI 0.0
Noble Hospital Clinical Research Department 1st Floor (Hadapsar, India) IND Dr. Rossi activated KRI 0.0
Christian Medical College (Vellore, India) IND Dr. Dubois activated KRI 0.0
Tata Memorial Hospital, Department of Medical Oncology (Mumbai, India) IND Dr. Kim activated KRI 0.0
Oncological Institute "Prof. Dr. I. Chiricuta", Cluj-Napoca (Cluj-Napoca, Romania) ROU Dr. Novak activated KRI 0.383
Clinical County Hospital Mures, Medical Oncology Department (Târgu Mureş, Romania) ROU Dr. Silva activated KRI 0.313
Spitalul Judetean de Urgenta "Dr. Constantin Opris" Baia-Mare, Sectia Oncologie (Baia Mare, Romania) ROU Dr. Jansen activated KRI 0.0
Medisprof SRL (Cluj-Napoca, Romania) ROU Dr. Kowalski activated KRI 0.0
State Healthcare Institution "Republican Clinical Oncological Center of the Ministry of Health of Republic of Tatarstan" (Kazan', Russia) RUS Dr. Clarke activated KRI 0.248
Blokhin Cancer Research Center (Moscow, Russia) RUS Dr. Moreau activated KRI 0.299
Municipal institution "Chernivtsi Regional Clinical Oncologic Dispensary" (Chernivtsi, Ukraine) UKR Dr. Ito activated KRI 0.0
Municipal Institution "Dnipropetrovsk City Multi-Field Clinical Hospital #4" of Dnipropetrovsk Regional Councel (Dnipropetrovsk, Ukraine) UKR Dr. Reyes activated KRI 0.0
State Institution "Institute of Medical Radiology named after S.P.Grygoryev of National Academy of Medical Sciences of Ukraine" (Kharkiv, Ukraine) UKR Dr. Nolan activated KRI 0.401
Lviv State Oncological Regional Treatment - Diagnostics Center, Chemotherapy Department (Lviv, Ukraine) UKR Dr. Okafor activated KRI 0.34
Vinnytsya Regional Clinical Oncologic Dispensary, Surgical Department (Vinnytsia, Ukraine) UKR Dr. Tanaka activated KRI 0.0

Monitoring visits 5

on_site 2026-10-03 risk-flagged

Proposed by centralized statistical monitoring (risk score 0.459, composite |z| 1.23): withdrawal rate 11% vs study mean 2%, z=3.01; SAE rate 0.68 vs study mean 0.31, z=2.29; enrollment per open month 1.46 vs study mean 1.71, z=-1.64. Pending CRA confirmation.

on_site 2026-10-03 risk-flagged

Proposed by centralized statistical monitoring (risk score 0.399, composite |z| 1.02): lab flags per patient 24.05 vs study mean 16.95, z=2.64. Pending CRA confirmation.

on_site 2026-10-13 risk-flagged

Proposed by centralized statistical monitoring (risk score 0.496, composite |z| 1.37): visit-window compliance 50% vs study mean 88%, z=-2.92; missed-visit rate 12% vs study mean 3%, z=2.73. Pending CRA confirmation.

on_site 2026-10-13 risk-flagged

Proposed by centralized statistical monitoring (risk score 0.359, composite |z| 0.89): enrollment per open month 2.11 vs study mean 0.67, z=3.36. Pending CRA confirmation.

on_site 2026-10-13 risk-flagged

Proposed by centralized statistical monitoring (risk score 0.34, composite |z| 0.83): lab flags per patient 18.00 vs study mean 9.74, z=2.54. Pending CRA confirmation.